ArticleFrontiers in immunology2026

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk.

Carl Vahldieck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.